Rapid Micro Biosystems (RPID) Equity Average (2020 - 2026)

Rapid Micro Biosystems' Equity Average history runs 7 years deep, the most recent figure standing at $26.8 million for Q1 2026.

• In Q1 2026, Equity Average fell 61.94% year-over-year to $26.8 million; the TTM figure through Mar 2026 stood at $26.8 million (down 61.94% YoY), while the FY2025 annual figure was $54.3 million, down 43.85% from the prior year.
• Equity Average came in at $26.8 million for Q1 2026 at Rapid Micro Biosystems, down from $38.8 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $214.0 million in Q1 2022 to a low of $26.8 million in Q1 2026.
• A 5-year average of $115.4 million and a median of $112.0 million in 2024 frame the typical range for Equity Average.
• Across the five-year window, Equity Average soared 432.6% in 2022 and slumped 61.94% in 2026, its largest moves.
• Rapid Micro Biosystems' Equity Average stood at $171.6 million in 2022, then slipped by 28.38% to $122.9 million in 2023, then tumbled by 35.01% to $79.9 million in 2024, then slumped by 51.46% to $38.8 million in 2025, then tumbled by 30.87% to $26.8 million in 2026.
• According to Business Quant data, Equity Average over the past three periods registered $26.8 million, $38.8 million, and $49.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison